NEW YORK (Reuters) - A federal judge has entered a consent decree and permanent injunction against a New Jersey compounding pharmacy after it was discovered that some of its products might be contaminated, the Food and Drug Administration said Friday.
Med Line Prep Consulting Inc compounded and distributed drugs for hospital and healthcare facilities. It ceased operations in March following a voluntary recall of products compounded at its facility in New Jersey.
The recall was prompted by the discovery of mold contaminating sterile bags of intravenous solution at a hospital in Connecticut.
The regulation of so-called compounding pharmacies, which combine, mix or alter medical ingredients, has been in the spotlight since a deadly meningitis outbreak last year linked to steroid injections ma,de by the New England Compound Center in Massachusetts.
No comments:
Post a Comment